Search for Clinical Trial Results

Sponsored By

Iron Overload - 12 Studies Found

Status Study
Completed Study Name: MRI Evaluation of Iron Overload in the Heart, Liver and Pancreas in Patients Receiving Multiple Blood Transfusions.
Condition: Iron Overload
Date: 2008-02-25
Completed Study Name: Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload
Date: 2005-10-14
Interventions: Drug: Deferasirox Other Name: ICL670
Completed Study Name: Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
Condition: Iron Overload
Date: 2008-04-02
Interventions: Drug: Deferasirox Other Name: ICL670
Completed Study Name: Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia
Condition: Iron Overload
Date: 2011-11-10
Interventions: Drug: Desferasirox Initial Dose: 20 mg/kg/d. Dose modification according to protocol.
Completed Study Name: A Study Assessing the Efficacy and Safety of Deferasirox in Patients With Transfusion-dependent Iron Overload
Condition: Transfusion-dependent Iron Overload
Date: 2005-09-13
Interventions: Drug: Deferasirox Other Name: ICL670
Completed Study Name: An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload
Condition: Transfusional Iron Overload in β-thalassemia
Date: 2005-09-12
Interventions: Drug: Deferasirox Tablets taken orally once a day.
Completed Study Name: Cytochrome P450 2E1 and Iron Overload
Condition:
  • Insulin Resistance
  • Iron Overload

Date: 2005-08-29
Interventions: Procedure: venesection Venesection therapy is realised every 7 - 14 days until iron desaturation complet
Completed Study Name: Effects of Phlebotomy on Insulin Sensitivity in Insulin Resistance-associated Hepatic Iron Overload Patients
Condition:
  • Insulin Resistance
  • Iron Overload

Date: 2011-05-17
Interventions:
  • Procedure: phlebotomy 7 ml/kg

Completed Study Name: Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia Major
Condition:
  • Thalassemia
  • Iron Overload

Date: 2011-07-11
Interventions: Drug: Amlodipine 5mg PO initially; may be reduced to 2.5mg PO if side effects
Completed Study Name: Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload
Condition:
  • Transfusional Iron Overload
  • Beta-thalassemia

Date: 2009-12-23
Interventions: Drug: FBS0701 Oral FBS0701 for 7 days at one of the following doses: 3 mg/kg/day or 8 mg/kg/day or 16 mg
Next >>>